Enlivex Pharmaceuticals

Developer of autologous and allogeneic cell immunotherapy therapy treatments

placeJerusalem, Jerusalem District, Israel calendar_todayFounded 2005 groups77 employees language enlivex.com

Registered entities

Social engagement

Social engagement: 2.3K social following, 10 posts in the last 12 months — below the industry typical range.

Investor mix

4 investors on record.

Investor typeCountShare
Venture capital250%
Bank & private debt125%
Other / undisclosed125%

Recent activity

2 Jul 2026
Milestone
revenue
26 Jun 2026
Milestone
revenue
25 Jun 2026
Milestone
users
Coming soon